Literature DB >> 6288992

Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.

D R Twardzik, S A Sherwin, J Ranchalis, G J Todaro.   

Abstract

Transforming growth factor (TGF) activities could be detected in the urine of normal, pregnant, and tumor-bearing humans. These acid- and heat-stable polypeptides competed for binding to epidermal growth factor (EGF) membrane receptors and promoted the anchorage-independent growth of nontransformed rodent cells. They differed from human EGF in their apparent molecular weights and soft-agar growth-stimulating activity. The urine from pregnant females contained TGF activities with apparent molecular weight(s) (relative) (Mr) of 10,000 ad 17,000--20,000. In the case of a lung cancer patient, an additional major activity of approximately 30,000--35,000 Mr was found. All urine specimens examined also contained a "common" 8,000-Mr soft-agar growth-stimulating activity, which competed for binding to EGF membrane receptors and which was chromatographically separable from EGF (urogastrone). Thus urine may provide a convenient and readily available source for the biochemical characterization of these TGF-like activities, some of which may be clinically useful biologic markers for certain types of cancer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288992

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC).

Authors:  A Francavilla; C Panella; A Amoruso; A Giangaspero; L Gennari; V Mazzaferro; G Colella; D H Van Thiel; T E Starzl
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells.

Authors:  R A Ignotz; B Kelly; R J Davis; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Hormones in breast fluid.

Authors:  D P Rose
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 4.  Peptide growth factors and inflammation, tissue repair, and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

5.  Transforming growth factor beta-like activity in human hydrocele fluid.

Authors:  P K Saha; S Kanda; H Morimitsu; N Nishimura; H Kanetake; Y Saito
Journal:  Urol Res       Date:  1990

6.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.

Authors:  V Samuels; J M Barrett; S Bockman; C G Pantazis; M B Allen
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Transforming growth factor-beta (TGF-beta) in human milk.

Authors:  S Saito; M Yoshida; M Ichijo; S Ishizaka; T Tsujii
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

Authors:  P Anklesaria; J Teixidó; M Laiho; J H Pierce; J S Greenberger; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.

Authors:  M A Anzano; A B Roberts; J M Smith; M B Sporn; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.

Authors:  A L Goldberg; I C Kettelhut; K Furuno; J M Fagan; V Baracos
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.